2026 SPEAKERS
Kevyn Adler, Senior Director, Market Access Product & Pipeline Strategy, Regeneron
Ana Filipa Alexandre, Senior Director, Pipeline Head for Neuroscience, Teva Pharmaceuticals
Marta Andreykiv, Head of Market Access Europe, Viatris
Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca
Sabrina Aouabed, Head of Market Access France, GSK
Jorge Arellano, Senior Vice President, Global Head, Value, Access, and Strategic Pricing, BioMarin
Carl Asche, Executive Director, Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy
Alex Bastian, Vice President, Commercial Strategy, Memo Therapeutics
Nadia Benhadi, Global Market Access & Pricing Director Specialty, GSK
Tomer Benzaken, Director, Head of Commercial Operations & Trade, Astellas
Katja Berg, Global Value and Access Strategy, BBU, AstraZeneca
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics
Angela Borghouts - de Ruijter, Associate Director Market Access, Gilead Sciences
Claire Boskamp, Senior Director GOVAP Analytics, Operational and Payer Excellence, Daiichi Sankyo
Vidya Breeveld, CEO, Transmineo
Henriette Burghoorn, Associate Director, Market Access, Gilead Sciences
Gorana Capkun, Vice President, Global Head of Patient Focused Real World Evidence, Merck Group
Lorenzo Capretto, Market Access Lead, Chiesi
Antonella Cardone, CEO, Cancer Patients Europe
Sandro Cesaro, Head of Europe Market Access & Pricing, AstraZeneca
Jag Chhatwal, Director, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School
José Luis Sánchez Chorro, Former Regional Pharmacy Director
Sally Chung, Vice President, Value & Access International Operations & Excellence, Ipsen
Amanda Cole, Director, Office of Health Economics
Catarina Costa-Pinheiro, Head of Global Pricing, Ferrer Internacional
Ms Delphine Courmier, Executive Director, Global Head of Pricing, Biosimilar Market Access, Organon
Nidhi Dani, Global Pricing and Market Access Director, GSK
Dr Rishi Das-Gupta, Chief Executive Officer, Health Innovation Network
Dalia Dawoud, Associate Director, Research, NICE
Silvia de Diego Blanco, Director, Global Market Access, Astellas
Rossella Di Bidino, Head of HTA for AI Unit, Graduate School of Health Economics and Management ALTEMS
Jose Diaz, Global Health Systems Economics & Value of Innovation, BMS
Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn
Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda
Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals
Patricia Dorling, Senior Director, Value & Implementation Outcomes Research, Oncology, Merck
Marcus Droege, Chief Commercial Officer, MUVON Therapeutics
Sara Engstrand, Senior Market Access Manager, Pfizer
Gina Ewy, Vice President, Head of Global Market Access, Hansa Biopharma
Stefaan Fiers, Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda
Lora Fleifel, Director, Market Access & Pricing, Europe, Oncology, Merck
Martina Garau, Director, Office of Health Economics
Loic Gauthier, Global Pricing Director, CSL Behring
Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson Innovative Medicine
Josie Godfrey, Independent Market Access and Rare Disease Adviser, Independent Rare Disease Expert
Wim Goettsch, Special Advisor HTA & Professor for HTA of Pharmaceuticals, Zorginstituut & Utrecht University
Thomas Grub, Director, Global Pricing and Market Access, medac GmbH
Neil Grubert, Global Market Access Expert, Independent
Josep Maria Guiu Segura, Director, Pharmacy and Medicines Area, Consorci de Salut i Social de Catalunya
Fabian Haacke, Director, Access Evidence, Santen
Steen Werner Hansen, Former Chair Danish Medicines Council, Danish Medicines Council
Mr Michael Happich, Senior Director, International Value & Access, Eli Lilly
Patrick Hopkinson, Managing Director, Independent HTA Expert
Mr Joel Iff, Executive Director, Global Access, Value & Evidence, Sarepta Therapeutics
Mohit Jain, Vice President, Market Access, International Operations, IntraBio
Sophie Janssens, Senior Vice President, Global Head, Early Patient Value Mission, UCB
Stephanie Juniat, Director, Alethira
Iroda Jurabekova, Global Director, Oncology Pricing and Market Access, Boehringer Ingelheim
Durgesh Kahol, Global Pricing and Market Access Director, GSK
Lisette Kaskens, Director, Value and Access, WECAN and Intercontinental, Ferring Pharmaceuticals
Mark Kewley, Director, London Secure Data Environment
Elizabeth Kinter, Vice President, Head of Global Market Access, Avidity Biosciences
Sandeep Kiri, Global Head, Health Economic Evidence, UCB
Sven Klijn, Director, HEOR Economic & Predictive Modeling, Bristol Myers Squibb
Katarzyna Kolasa, Director, Digital Health Center, Kozminski University
Tasi Lampropoulou, Director, Global Integrated Evidence Planning, Novartis
Walmon Leal, Vice President, Head of Global Pricing, Tenders & Contracts, Viatris
Charles Makin, Head of US Real World Evidence & Epidemiology, Boehringer Ingelheim
Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, Bristol Myers Squibb
Chris Mancill, Senior Vice President, Head, US Market Access, AstraZeneca
Silvy Mardiguian, Senior Director, Head of HEOR, Europe & New Markets, BeOne Medicines
Sandra Margunato Debay, Senior Director, Global Market Access and Pricing, Genmab
Vivian Mendonca, Senior Vice President, Global Head - Value Evidence and External Affairs (G-VEEA), Menarini Group
Vanessa Mirsky, Vice President, Life Sciences Data Strategy, RWE/RWD, OneOncology
Lorenzo Montrasio, Independent Advisor, European commission
Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine
Helder Mota Filipe, President, Portuguese Pharmaceutical Association
Helder Mota-Filipe, President, Portuguese Pharmaceutical Association
Michael Mueller, Head of Market Access, Western Europe, Sun Pharma
Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Anh Bourcet Nguyen, Senior Director, Market Access & Public Affairs, APAC, Novo Nordisk
Eric Noehrenberg, Founder, NIPC
Andrew Olaye, Executive Director, Head of Market Access EMEA, Orchard Therapeutics Ltd
Melvin Skip Olson, Founder, Olson Strategies GmbH
Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda
Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics
Gianfranco Parlato, Global Head of Value Access & Pricing CVMD (CardioMetabolism & Venous Disease), Servier Monde
Lotta Parviainen, Global Market Access Director, Zambon France
Dilip Patel, SVP, Access & Market Development, Autolus
Peter Pemberton-Ross, Head, HE & HTA Strategy, Biogen International GmbH
Luca Luigi Polastri, Global Value and Access Head, Nephrology Franchise, Kyowa Kirin
Annette Powers, Senior Vice President, Global Market Access & HEOR, Bristol Myers Squibb
Arup Pramanik, Corporate Vice President, Global Market Access, Boehringer Ingelheim
Jonathan Randell, Head of Value and Access, UK & Ireland, Biogen
Sandra Rose, Head of Market Access & Public Affairs, Chiesi
James Rose, Director of Industry Partnerships, Health Innovation Oxford
Sandy Ruiz, Senior Director, Market Access, Pricing & HEOR, Immunocore
Natalia Scherff, Leadership Coach, ICF PCC, Coach Scherff
Mr Krijn Schiffers, Operations Lead, Europe, Merck KgaA
Fabian Schmidt, Global Head of Value, Access & Policy, RECORDATI Rare Diseases
Ayman Semaan, Head of Market Access & Pricing, Biologix
Hans Severens, Independent HTA Expert, Severens HTA consultancy
Kun Shi-van Wielink, Director, HEOR/RWE, Market Access, EMEA, Santen
Hedwig Silies, Senior Director, Pricing & Market Access, DACH & Nordic Countries Lead, Blueprint Medicines
Anupama Rao Singh, Vice President, LATAM/Head Oncology COE, Dr. Reddy's Laboratories Ltd.
Jiri Smejkal, Global Head of Pricing & Tender Excellent for PDT, Takeda
Joshua Smeltzer, Global Pricing Director, Ipsen Pharma GmbH
Valentina Strammiello, Director of Strategic Initiatives, European Patients' Forum
Giovanni Tafuri, Senior Director, International Market Access and Pricing, Madrigal Pharmaceuticals
Dr Peter Takacs, Head of Global Market Access, Miltenyi Biomedicine
Neeta Tandon, Vice President, Value & Evidence Scientific Engagement, Johnson & Johnson Innovation
Siguroli Teitsson, Director, GHEOR Economic & Predictive Modeling, Bristol Myers Squibb
Ilona Torontali, Vice President, Global Pharma Pricing and Reimbursement, Roche
Mondher Toumi, Professor of Public Health, Aix-Marseille University
Emmanouil Tsiasiotis, Research Project Manager and Coordinator, EDiHTA
Aodan Tynan, Head of Access Implementation, Pricing & Value Demonstration, Astellas
Carin Uyl-de Groot, Professor of HTA, Erasmus University Rotterdam
Cristina Valencia, Associate Director, Real World Evidence, Takeda
Goedele van Haasteren, Deputy Chief of the HTA Unit, Federal Office of Public Health, Switzerland
Chantal van Litsenburg, Manager, Translational Effectiveness, Leiden University Medical Center (Netherlands)
Floortje van Nooten, Head of Market Access EU, Shionogi BV
Oliver van Zon, VP Market Access Europe, Crinetics Pharmaceuticals
Yvette Venable, Global Director of Payer Partnerships and Policy, AstraZeneca
Ms Rosa Maria Vivanco Hidalgo, Head of Health Technology Assessment, AQuAS Gencat
Reg Waldeck, Vice President, Head Global Market Access, Bayer
Rhys Williams, Vice President, Evidence Generation Strategy and Health Economics, Global Medical Affairs (ex-China), BeOne Medicines
Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group
Nicole Yurgin, Founder & RWE Expert, Yurgin Advisory
Mrs Natasa Zibelnik, EMEA Head of Market Access, Oncology, Menarini Stemline
Get Involved
Sponsorship & Exhibition Sales
Oliver Hersey-Swan
oliver.hersey-swan@terrapinn.com
Conference Production
George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940
Marketing Opportunities
Emily Ngai
emily.ngai@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events